An agile specialty pharmaceutical R&D Team
Ethypharm’s research and development (R&D) is focused on developing new products which will fulfil unmet medical needs within both critical care situations, and in the treatment of central nervous system diseases and conditions.
Our R&D model
We have expertise at all stages of pharmaceutical development from early pipeline evaluation and selection to launching products within international markets. Our experienced R&D teams, comprising of more than 80 professionals located in France, the United Kingdom, and China, are combining their efforts with external partners to ensure time-to-market efficiency and the success of projects.
Open innovation strategy
There are many great ideas generated by healthcare professionals who are in contact with patients on a daily basis. There may be innovations that we are not currently developing that could benefit patients. For this reason, we are open to exploring new possibilities and listening to ideas from outside of our organisation.
If you have an R&D project in the areas of critical care, or in the treatment of the central nervous system diseases or conditions, please share it with us to see how we could accelerate its development together.
If you are looking to create value with an asset that fits our strategic focus, feel free to send us a message via our contact page, and we will get back to you shortly.